Literature DB >> 9681326

A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood.

G Skopp1, L Pötsch, B Ganssmann, R Aderjan, R Mattern.   

Abstract

The distribution of morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) in whole blood, plasma, and packed erythrocytes was studied. Parameters investigated were the hematocrit values (10, 42, 44, and 71%) and the water content of the samples. The blood-to-plasma ratio of morphine concentrations was unaffected by variations in hematocrit and water content, whereas the corresponding ratios for M3G and M6G were strongly influenced. Ratios were 0.53 to 0.65 and 0.52 to 0.62 in specimens with average hematocrit values (42 and 44%, respectively), and the ratios were 0.81 or 0.89 (hematocrit 10%) and 0.27 or 0.28 (hematocrit 71%) in blood samples with different hematocrit values. In contrast to the morphine conjugates, morphine was highly bound to or partitioned into red blood cells (beta e = 55.9). Although the present data are limited, they already demonstrate that conclusions drawn from pharmacokinetic studies and transferred to parent drug to metabolite ratios resulting from forensic blood samples may be biased by the particular biological matrix under investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681326     DOI: 10.1093/jat/22.4.261

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  12 in total

1.  Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.

Authors:  M R Bouw; R Xie; K Tunblad; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  The postmortem redistribution of iso-α-acids in postmortem specimens.

Authors:  Luke N Rodda; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2014-10-16       Impact factor: 2.007

3.  Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.

Authors:  R Xie; M R Bouw; M Hammarlund-Udenaes
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.

Authors:  M R Bouw; M Gårdmark; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

5.  Morphine blood-brain barrier transport is influenced by probenecid co-administration.

Authors:  Karin Tunblad; E Niclas Jonsson; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

6.  Direct nose-to-brain transfer of morphine after nasal administration to rats.

Authors:  Ulrika Espefält Westin; Emma Boström; Johan Gråsjö; Margareta Hammarlund-Udenaes; Erik Björk
Journal:  Pharm Res       Date:  2006-02-25       Impact factor: 4.200

7.  Scalable in silico Simulation of Transdermal Drug Permeability: Application of BIOiSIM Platform.

Authors:  Neha Maharao; Victor Antontsev; Hypatia Hou; Jason Walsh; Jyotika Varshney
Journal:  Drug Des Devel Ther       Date:  2020-06-11       Impact factor: 4.162

8.  From Pediatric Covariate Model to Semiphysiological Function for Maturation: Part II-Sensitivity to Physiological and Physicochemical Properties.

Authors:  E H J Krekels; T N Johnson; S M den Hoedt; A Rostami-Hodjegan; M Danhof; D Tibboel; C A J Knibbe
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-10-10

9.  Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter.

Authors:  C Emoto; T Fukuda; T N Johnson; S Neuhoff; S Sadhasivam; A A Vinks
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-12-09

10.  Physiologically-Based Pharmacokinetic Model of Morphine and Morphine-3-Glucuronide in Nonalcoholic Steatohepatitis.

Authors:  Noora Sjöstedt; Sibylle Neuhoff; Kim L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2020-11-06       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.